RBC Life Sciences, Inc. Share Price

Equities

RBCL

US74926T2015

Other Specialty Retailers

Market Closed - OTC Markets 17:22:09 18/04/2024 BST 5-day change 1st Jan Change
0.000067 USD -33.00% Intraday chart for RBC Life Sciences, Inc. 0.00% 0.00%
Sales 2013 25.47M 2.04B Sales 2014 28.27M 2.26B Capitalization 2.88M 230M
Net income 2013 - 0 Net income 2014 - 0 EV / Sales 2013 0.04 x
Net cash position 2013 2.4M 192M Net cash position 2014 785K 62.84M EV / Sales 2014 0.07 x
P/E ratio 2013
-6.74 x
P/E ratio 2014
-4.77 x
Employees 89
Yield 2013 *
-
Yield 2014
-
Free-Float 91.69%
More Fundamentals * Assessed data
Dynamic Chart
RBC Life Sciences, Inc. Approves Resignation of Robert A. Kaiser as a Director CI
Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. CI
Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. CI
RBC Life Sciences Inc.'s Equity Buyback announced on August 28, 2013, has expired with 0 shares, representing 0% for $0 million. CI
RBC Life Sciences Inc. Announces Executive Changes CI
Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. CI
RBC Life Sciences Inc. Announces Executive Changes CI
RBC Life Sciences Inc. Enters into Two-Year Exclusive Distributorship Agreement with Coral Club International, Inc CI
RBC Life Sciences, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014 CI
Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. CI
RBC Life Sciences, Inc. Announces Executive Changes, Effective June 13, 2014 CI
RBC Life Sciences Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2014 CI
Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. CI
RBC Life Sciences Inc. Announces Unaudited Consolidated Earnings Results for the Year Ended December 31, 2013 CI
Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. CI
More news
1 day-33.00%
6 months-66.67%
More quotes
1 month
0.00
Extreme 6.7E-5
0.00
Current year
0.00
Extreme 6.7E-5
0.00
1 year
0.00
Extreme 6.7E-5
0.00
3 years
0.00
Extreme 6.7E-5
0.20
5 years
0.00
Extreme 6.7E-5
0.49
10 years
0.00
Extreme 6.7E-5
1.85
More quotes
Managers TitleAgeSince
President - -
Members of the board TitleAgeSince
President - -
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 18, 2024 at 05:22 pm

More quotes
RBC Life Sciences, Inc. is engaged in the marketing of nutritional supplements and personal care products through subsidiaries in North America and Southeast Asia and through licensees in Russia/Eastern Europe. The Company's segments include Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in over three categories: wellness products, fitness products and personal care products. Its Medical Products segment distributes wound care products. Nutritional Products are marketed under the RBC Life brand name. As of September 30, 2015, its Nutritional Products segment manufactured and distributed a line of over 100 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. As of September 30, 2015, it marketed a line of over 35 wound care products under the MPM Medical brand name through a subsidiary operating primarily in the United States.
More about the company